Skip to main content

We’ve updated our Terms & Conditions and Privacy Policy. By using this site, you agree to these terms.

Prestigious award validates Geisinger’s focus on accurate and timely clinical data

DANVILLE, Pa. –  Geisinger has become the first healthcare system in Pennsylvania and the fourth in the world to earn the prestigious HIMSS Analytics Stage 6 Adoption Model for Analytics Maturity (AMAM℠) validation. This award recognizes integrated application of information systems and analytics to improve clinical, operational, research and financial processes for healthcare.  

"Geisinger is proud to join a handful of healthcare organizations in the world to reach this level of analytics maturity. We strive to provide our patients with the best possible outcomes through innovative technologies and progressive use of data-driven decisions," said Geisinger Chief Information Officer John Kravitz. "Geisinger’s clinically integrated environment ensures data flows seamlessly from one department to another, prioritizing patient care." 

HIMSS Analytics, a global healthcare IT market intelligence, research and standards organization, developed the AMAM as a methodology to measure and advance an organization's analytics capabilities. This international eight-stage (Stage 0 - Stage 7) model measures the capabilities an organization has gained from the installation of data warehousing technology and data governance to assure validated data as a foundation for traditional and creative applications. 

Geisinger has achieved AMAM Stage 6, emphasizing a strong foundation of data content, infrastructure, data governance and analytics competency.

Only two organizations in the world have reached the next, prestigious AMAM Stage 7 -- Duke Health and University of North Carolina Health. Geisinger joins Rush Health in Chicago and King Faisal Specialist Hospital & Research Centre in Saudi Arabia as the next Stage 6 achievers. 

The recognition complements Geisinger’s recent validation as a clinical inpatient Stage 7 health system, as tracked by the HIMSS Electronic Medical Record Adoption Model (EMRAM℠). The health system validated at Stage 7 for the outpatient adoption model as well. In contrast to AMAM validations, over 350 organizations have achieved EMRAM Stage 7.

"The future of healthcare delivery is in data analytics and personalized medicine, so we are honored to be recognized by HIMSS Analytics for this achievement," said Dr. Mark Poler, a Physician Informaticist participating in the HIMSS AMAM validation process. “This continued recognition shows Geisinger is building upon a foundation of improved care quality, safety and efficiency.” 

About Geisinger
Geisinger is among the nation’s leading providers of value-based care, serving 1.2 million people in urban and rural communities across Pennsylvania. Founded in 1915 by philanthropist Abigail Geisinger, the nonprofit system generates $10 billion in annual revenues across 126 care sites — including 10 hospital campuses — and Geisinger Health Plan, with more than half a million members in commercial and government plans. Geisinger College of Health Sciences educates more than 5,000 medical professionals annually and conducts more than 1,400 clinical research studies. With 26,000 employees, including 1,700 employed physicians, Geisinger is among Pennsylvania’s largest employers with an estimated economic impact of $15 billion to the state’s economy. On March 31, 2024, Geisinger became the first member of Risant Health, a new nonprofit charitable organization created to expand and accelerate value-based care across the country. Learn more at or follow on Facebook, Instagram, LinkedIn and X.

geisinger placeholder
For media inquiries, contact our team.
Content from General Links with modal content